Hematocrit and the risk of recurrent venous thrombosis: A prospective cohort study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Eischer, Lisbeth ^a   Tscholl, Verena ^a   Heinze, Georg ^a   Traby, Ludwig ^a   Kyrle, Paul A ^a   Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM; AUSTRIA; BIOASSAY; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; VEIN THROMBOSIS;

AUSTRIA; COHORT STUDIES; ENDPOINT DETERMINATION; FEMALE; HEMATOCRIT; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC; VENOUS THROMBOSIS;

EID: 84862000489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038705     Document Type: Article

References (19)

1. Kyrle PA, Rosendaal FR, Eichinger S, (2010) Risk assessment of recurrent venous thrombosis. Lancet 376: 2032-2039.
2. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, et al. (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179: 417-426.
3. Eichinger S, Heinze G, Jandeck LM, Kyrle PA, (2008) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121: 1630-1636.
4. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, et al. (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350: 2558-2563.
5. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C, (2006) Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 368: 371-378.
6. Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, et al. (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342: d813.
7. Bloom AL CDF, Duncan TP, Tuddenham, (1994) EGD: Haemostasis and thrombosis. Longman Group UK; Churchill Livingstone Edinburgh London Madrid Melbourne New York And Tokyo 2: 1169-1188.
8. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, et al. (1991) Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87: 571-580.
9. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, et al. (1991) Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 78: 154-162.
10. Gruppo Italiano Studio Policitemia, (1995) Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 123: 656-664.
11. Schafer AI, (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64: 1-12.
12. Vayá A, Mira Y, Martínez M, Villa P, Ferrando F, et al. (2002) Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc 26: 41-53.
13. Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen JB, (2010) Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica 95: 270-275.
14. Brandt JT, Triplett DA, Alving B, Scharrer I, (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74: 1185-1190.
15. Kalbfleisch JD, Prentice RL, (1980) The Statistical Analysis of Failure Time Data (Wiley Series in Probability and Statistics). Wiley-Interscience.
16. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481.
17. Royston P, Sauerbrei W, (2008) Multivariable Model-building - A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Chichester Wiley.
18. Lin DY, Fleming TR, De Gruttola V, (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Statistics in Medicine 16: 1515-1527.
19. Heinze G, Schemper M, (2001) A solution to the problem of monotone likelihood in Cox regression. Biometrics 57: 114-119.